PREVACID NAPRAPAC 500 (COPACKAGED) Drug Patent Profile
✉ Email this page to a colleague
When do Prevacid Naprapac 500 (copackaged) patents expire, and what generic alternatives are available?
Prevacid Naprapac 500 (copackaged) is a drug marketed by Takeda Pharms Na and is included in one NDA.
The generic ingredient in PREVACID NAPRAPAC 500 (COPACKAGED) is lansoprazole; naproxen. There are fifty-six drug master file entries for this compound. Additional details are available on the lansoprazole; naproxen profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for PREVACID NAPRAPAC 500 (COPACKAGED)?
- What are the global sales for PREVACID NAPRAPAC 500 (COPACKAGED)?
- What is Average Wholesale Price for PREVACID NAPRAPAC 500 (COPACKAGED)?
Summary for PREVACID NAPRAPAC 500 (COPACKAGED)
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Formulation / Manufacturing: | see details |
DailyMed Link: | PREVACID NAPRAPAC 500 (COPACKAGED) at DailyMed |
![PREVACID NAPRAPAC 500 (COPACKAGED) drug patent expirations Drug patent expirations by year for PREVACID NAPRAPAC 500 (COPACKAGED)](/p/graph/s/t/PREVACID_NAPRAPAC_500_(COPACKAGED)-patent-expirations.png)
US Patents and Regulatory Information for PREVACID NAPRAPAC 500 (COPACKAGED)
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Takeda Pharms Na | PREVACID NAPRAPAC 500 (COPACKAGED) | lansoprazole; naproxen | CAPSULE, DELAYED REL PELLETS, TABLET;ORAL | 021507-004 | Nov 14, 2003 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for PREVACID NAPRAPAC 500 (COPACKAGED)
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Takeda Pharms Na | PREVACID NAPRAPAC 500 (COPACKAGED) | lansoprazole; naproxen | CAPSULE, DELAYED REL PELLETS, TABLET;ORAL | 021507-004 | Nov 14, 2003 | ⤷ Sign Up | ⤷ Sign Up |
Takeda Pharms Na | PREVACID NAPRAPAC 500 (COPACKAGED) | lansoprazole; naproxen | CAPSULE, DELAYED REL PELLETS, TABLET;ORAL | 021507-004 | Nov 14, 2003 | ⤷ Sign Up | ⤷ Sign Up |
Takeda Pharms Na | PREVACID NAPRAPAC 500 (COPACKAGED) | lansoprazole; naproxen | CAPSULE, DELAYED REL PELLETS, TABLET;ORAL | 021507-004 | Nov 14, 2003 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for PREVACID NAPRAPAC 500 (COPACKAGED)
See the table below for patents covering PREVACID NAPRAPAC 500 (COPACKAGED) around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Japan | H0244473 | ⤷ Sign Up | |
Latvia | 5775 | Piridina atvasinajumi un to iegusanas panemiens | ⤷ Sign Up |
Canada | 1338399 | COMPOSITION PHARMACEUTIQUE STABILISEE ET SA PREPARATION (STABILIZED PHARMACEUTICAL COMPOSITION AND ITS PRODUCTION) | ⤷ Sign Up |
>Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for PREVACID NAPRAPAC 500 (COPACKAGED)
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
0174726 | 93C0021 | Belgium | ⤷ Sign Up | PRODUCT NAME: LANSOPRAZOLE; NAT. REG.: 150 S 539 F 4 19921119; FIRST REG.: FR 333 412.1 19901211 |
0174726 | SPC/GB94/011 | United Kingdom | ⤷ Sign Up | SPC/GB94/011, EXPIRES: 20051210 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |